Co-Authors
This is a "connection" page, showing publications co-authored by Karolina Akinosoglou and Maria Kosmidou.
Connection Strength
0.119
-
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
Score: 0.060
-
An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
Score: 0.058
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.